207 related articles for article (PubMed ID: 21504710)
21. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
22. HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma.
Lau DT; Norris MD; Marshall GM; Haber M; Ashton LJ
Tissue Antigens; 2011 Dec; 78(6):421-7. PubMed ID: 22115424
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in array comparative genomic hybridization technologies and their applications in human genetics.
Lockwood WW; Chari R; Chi B; Lam WL
Eur J Hum Genet; 2006 Feb; 14(2):139-48. PubMed ID: 16288307
[TBL] [Abstract][Full Text] [Related]
24. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
[TBL] [Abstract][Full Text] [Related]
25. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
26. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
Alberti C
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
[TBL] [Abstract][Full Text] [Related]
27. Childhood acute lymphoblastic leukemia in the age of genomics.
Carroll WL; Bhojwani D; Min DJ; Moskowitz N; Raetz EA
Pediatr Blood Cancer; 2006 May; 46(5):570-8. PubMed ID: 16365862
[TBL] [Abstract][Full Text] [Related]
28. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.
Nakagawara A; Ohira M
Cancer Lett; 2004 Feb; 204(2):213-24. PubMed ID: 15013220
[TBL] [Abstract][Full Text] [Related]
31. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
[TBL] [Abstract][Full Text] [Related]
32. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
33. Genetic discoveries and treatment advances in neuroblastoma.
Bagatell R; Cohn SL
Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
[TBL] [Abstract][Full Text] [Related]
34. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
[TBL] [Abstract][Full Text] [Related]
35. Genetic susceptibility to neuroblastoma: current knowledge and future directions.
Ritenour LE; Randall MP; Bosse KR; Diskin SJ
Cell Tissue Res; 2018 May; 372(2):287-307. PubMed ID: 29589100
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma genetics and phenotype: a tale of heterogeneity.
Speleman F; De Preter K; Vandesompele J
Semin Cancer Biol; 2011 Oct; 21(4):238-44. PubMed ID: 21839839
[TBL] [Abstract][Full Text] [Related]
37. Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.
Theruvath J; Russo A; Kron B; Paret C; Wingerter A; El Malki K; Neu MA; Alt F; Staatz G; Stein R; Seidmann L; Prawitt D; Faber J
Pediatr Hematol Oncol; 2016 May; 33(4):264-75. PubMed ID: 27285993
[TBL] [Abstract][Full Text] [Related]
38. Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
Ohira M; Nakagawara A
Cancer Sci; 2010 Nov; 101(11):2295-301. PubMed ID: 20731666
[TBL] [Abstract][Full Text] [Related]
39. Genomics in multiple myeloma research.
Sevcíková S; Nemec P; Pour L; Hájek R
Klin Onkol; 2011; 24 Suppl():S34-8. PubMed ID: 21923062
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into the biology of neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Delattre O
Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
